Click on each picture to be linked to matching website.
Craig R. Smith, MD, FACS
Dr. Craig R. Smith Named Chair of Surgery and Surgeon-in-Chief at Columbia University Medical Center and NewYork-Presbyterian/Columbia January 29, 2010
Newswise — One of the nation's leading cardiac surgeons, Dr. Craig R. Smith has been appointed chairman of the Department of Surgery at Columbia University College of Physicians and Surgeons and surgeon-in-chief at NewYork-Presbyterian Hospital/Columbia University Medical Center and its Vivian and Seymour Milstein Family Heart Center. Dr. Smith, the Calvin F. Barber Professor of Surgery, has served as interim chair of the department since 2007.
With a roster of nearly 100 full-time faculty members with specialties ranging from basic science research to the most advanced robotic surgical procedures, 89 fellows and residents, and more than 330 staff members, the Department of Surgery at NewYork-Presbyterian/Columbia draws on a tradition of more than 225 years of distinction in patient care, research and education.....continue reading
Cardiorobotics expands to Massachusetts January 27, 2010
Medical-technologies developer Cardiorobotics Inc., a medical device startup, has opened a new office in Massachusetts.
The company is headquartered in Newport, R.I., and has taken on a new 14,500-square-foot lease at 475 Paramount Drive in Raynham, Mass.
Cardiorobotics is developing robot technologies for use in a wide range of surgical and interventional applications, including minimally invasive cardiac surgery. Cardiorobotics currently has 13 employees spread between its Newport and Pittsburgh, Pa., offices.
Earlier this month, the company landed $5 million in venture capital from undisclosed investors. That followed a June Series A funding round that brought in $11.6 million from Pittsburgh-based Eagle Ventures, the Pittsburgh Life Sciences Greenhouse and the Slater Technology Fund. At the time, the company said it planned to use the funding for a clinical trial of its product on humans and to commercialize the product.
One of the high-end virtual reality surgical simulators.
Qatar Robotic Surgery Centre (QRSC), which is to start its activities in May this year at the Qatar Science and Technology Park, has taken delivery of three high-end virtual reality surgical simulators.
The 3 LapVR systems that QRSC has acquired are the first Immersion Medical brand surgical simulators in the region. With six more machines to come in the following years, this is the first step in establishing the region’s largest surgical simulation facility.
The laparoscopy simulators allow surgeons to be trained on a virtual patient in minimal invasive surgery. QRSC will showcase surgical simulation, which constitutes an essential part of its robotic surgery training activities, at Arab Health which begins in Dubai today.
QRSC, which seeks to become a focal point for international expertise in robotic surgery, will develop three core activities: demonstration of surgical technologies, training of medical and non-medical staff and technology development....continue reading
SQUIGGLE RV Micromotor Creates New Possibilities in Medical Technology January 15, 2010
We typically don't profile individual components that make up the insides of medical devices, but when we see a tiny novel motor come to market, we get excited of its potential to miniaturize all kinds of gadgets. New Scale Technologies out of Victor, NY has released the ultrasonic SQUIGGLE RV motor system that is only 2.8mm wide and can drive a shaft at 10 mm /sec. And it does this at .5μm resolution (that's half a millionth of a meter). It seems that where small size and precision are key, such as in invasive medical devices, a motor so small could open new possibilities in angio interventions, laparoscopy, drug delivery, and therapeutic systems.
Some ideas for medical applications of the device:
•Robotic surgical devices. SQUIGGLE motors and TRACKER position sensors can be used for everything from robotic grippers and retractors to miniature mobile robots for minimally invasive surgery. •Endoscopes. Small enough to fit inside the head of a standard endoscope, SQUIGGLE motors and TRACKER position sensors can add more capabilities: focus a lens, manipulate a scraper, collect a sample, dispense a liquid. •Implantable devices. The SQUIGGLE motor would allow adjustment of implanted devices in situ, preserving optimal performance.
has joined the Department of Urology as assistant professor and director of robotic surgery at NewYork-Presbyterian/Columbia University.
Dr. Badani received his medical degree from Case Western Reserve University School of Medicine and did both urologic residency and fellowship training in robotic and laparoscopic urologic oncology at the Vattikuti Urology Institute, Henry Ford Hospital (Detroit).
Dr. Badani has developed standardized techniques for robotic kidney and adrenal surgery and has helped pioneer novel techniques to preserve potency and optimize cancer control in men undergoing robotic prostatectomy.
Dr. Badani's major clinical and research interests include the treatment of malignancies of the genitourinary tract (including prostate, bladder, kidney, and adrenal disorders) and the development of new robotic surgery technologies and techniques. For more information Click here
The Robotics Center at NewYork-Presbyterian Hospital/Columbia University Medical Center is one of only a few medical centers in the world with the expertise to offer comprehensive, minimally invasive robotic surgery of the prostate (prostatectomy), kidney (nephrectomy), bladder (cystectomy), and adrenal gland.
He was fellowship-trained in laparoscopic and robotic oncology under the mentorship of Mani Menon, MD, and spent six years at the Vattikuti Urology Institute in Detroit, Michigan, where robotic prostatectomy was developed and where more robotic prostatectomy procedures have been performed than any other hospital or medical center in the world....continue reading
Robotic Prostatectomy Expert Dr. David Samadi, MD Stresses the Importance of a Surgeon's Experience in Robotic Surgery Jan. 12, 2010. By marketwire
The 2005 study focused on radical prostatectomy (removal of the prostate gland), performed laparoscopically, traditionally and with robotics. The results were that more than a quarter of the 933 doctors studied had performed just one surgery that year. Moreover, 80 percent of the surgeons performed 10 or fewer procedures. Previously, it had been determined by researchers at Memorial Sloan-Kettering that an experienced surgeon needed to perform about 250 radical prostatectomies for the best outcomes. The study concluded that many of the surgeons would not be able to achieve that number of procedures in their entire career.
According to the research, only two percent of surgeons in the country, and four percent in New York, could be considered high-volume surgeons. Due to large, specialized cancer treatment centers, New York has the largest concentration of high-volume prostate cancer surgeons, including Dr. Samadi, who has performed over 2,100 successful procedures in his Manhattan practice....continue reading
Dr. Bryant Whiting, a urology resident, assists Dr. Sijo Parekattil with a robotic surgery to reverse a vasectomy
UF study: State-of-the-art robotic procedure can cut 20 minutes off a vasectomy reversal January 12, 2010
GAINESVILLE - Cutting 20 minutes off the time spent in surgery to reverse a vasectomy might not seem like much. But to a couple trying to get pregnant, it can be a very big deal. That's the view of Dr. Sijo Parekattil, director of male infertility and microsurgery at the University of Florida.
Parekattil recently completed a year-long study looking at the time needed to perform vasectomy reversal using robot-assisted surgery compared with conventional surgery in which the surgeon is aided by a microscope.....Continue reading
The Methodist DeBakey Heart & Vascular Center Purchases Third Sensei X Robotic Catheter System; Opens New Vascular Research Laboratory
Methodist Selected as a Hansen Medical Center of Excellence for Sensei X Robotic Catheter Platform January 12, 2010
Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in flexible medical robotics and the developer of robotic technology for accurate 3D control of catheter movement, today announced that the Methodist DeBakey Heart & Vascular Center in Houston has purchased its third Sensei® X Robotic Catheter System.
Methodist has also opened a new Vascular Research Laboratory, where physicians will use the Sensei X and other flexible robotics technology to research pre-clinical capabilities in vascular surgery including procedure targets in the peripheral vasculature and the abdominal and thoracic aorta, as well as developing procedures in structural heart disease.
In addition, Hansen Medical selected Methodist to be a Center of Excellence where physicians from around the globe will have the opportunity to be trained on flexible robotics with world-renowned physicians in a high-volume electrophysiology lab. The new Center of Excellence commenced operation in late December 2009.
"The Methodist DeBakey Heart & Vascular Center is delighted to be the first center in the world with three Sensei X robots," said Alan B. Lumsden, M.D., medical director of the Methodist DeBakey Heart & Vascular Center and chair of the department of cardiovascular surgery at The Methodist Hospital. "Because of the close collaboration between cardiologists and cardiovascular surgeons in our center, we have rapidly shared both our skills and the medical robotic technology between electrophysiology and vascular surgery. We view the convergence of flexible catheter robotics and advanced imaging systems as the new frontier in performing endovascular procedures. For complete story Click here
Virtual 3D Liver Surgery System Helps Surgeons Practise For Real Thing January 11, 2010
Surgeons can now practise keyhole surgery to remove tumors on a "virtual 3D liver" before doing it in real patients; the new system, developed under the pan-European EUREKA Odysseus project, will help to reduce risks to patients and also enable surgeons to take expert advice before doing operations.
Over 44 months and at a cost of more than 7 million Euros, German, French and Norwegian teams working on the the Odysseus project, also known as EUREKA project E! 3184, have developed systems that allow an expert to see 3D images of the liver of an individual patient.
The Odysseus images are created using information from MRI and CT scans and show the liver and its tumors or other pathologies.
Surgeons can send the reconstructions electronically to other experts, allowing them to consult in real time just before carrying out the procedure, get diagnostic support and make collaborative decisions about the best way to plan and do the operation....Continue reading
Removing heart tumour can also be bloodless January 10, 2010
BANGALORE: In a breakthrough in cardiac care, Bangalore-based HCG Hospitals has successfully removed a tumour in the left ventricle of the heart through CyberKnife, a bloodless and painless surgery performed by a robotic system that uses artificial intelligence.
Said to be a first in the world, the treatment was done on a 29-year-old techie whose tongue cancer spread to the neck and then the heart. Hitherto, CyberKnife has been used to treat tumour of the brain, lungs, liver, prostate and spine without causing damage to other organs.
"Three weeks ago, when we noticed lesions on the left ventricle, we knew the cancer was spreading. Surgery would have been a huge risk. For us, it was a challenge. By using the PET scan and spinal tracking system, we zeroed in on the tumour and destroyed it. During the procedure, we used medication to slow down the heart," hospital chairman and radiation oncologist Dr B S Ajaikumar told STOI.
The 5-day procedure was completed last week. Five fractions of CyberKnife were given to heart lesions and three fractions to adrenal lesions in the same session. "Since it was the first time in the world that CyberKnife was used on the left ventricle, we took a second opinion from Stanford University. We knew CyberKnife could one day be used to correct abnormal heart rhythms, replacing the current invasive surgery with painless laser zaps," he added. For complete story Click here
Personalized liver surgeries are already possible at five test hospitals in France Canada and Switzerland
Tool Allows Liver-Surgery Practice Before people go under the knife
Experts with the EUREKA project Odysseus announce that they have just finished developing a new tool aimed at making it easier for surgeons to conduct complex liver surgeries. The same method is bound to benefit the patients as well, as they ultimately stand to gain or lose from the experience, or lack thereof, of their surgeons. The new tool reportedly advances healthcare experts' understanding of how the human liver is segmented, by generating an accurate, 3D representation of the blood vessels within one of the human body's major organs, AlphaGalileo reports.
The method revolves around using a software to combine pieces of data collected via Magnetic Resonance Imaging (MRI) and computed tomography (CT) scans. The datasets can then be transmitted to any consultants anywhere in the world, and the course of the operation can be established while the procedures are ongoing (in real-time), or shortly before the patient is placed on the operating table. The best possible diagnostic support, as well as the best informed collaborative decisions thus become possible, potentially increasing a patient's chances of pulling through complex procedures.
The tool also allows for the simulation of laparoscopic and robotic surgery, which could prove invaluable for training future generations of surgeons. Aspects such as tissue resistance are also factored into the simulation, which means that those practicing on it will get as close to the real deal as possible without actually touching a live liver. “Thanks to the 3D modeling, the future of liver surgery has gained more precision through accurate definition of the liver's blood vessels,” Institut de Recherche pour les Cancers de l'Appareil Digestif (IRCAD) researcher, Professor Luc Soler says.
Saint Joseph's Hospital Announces First Radical Robotic Cystectomy January 9, 2010
PRLEAP.COM Saint Joseph’s Hospital of Atlanta recently performed its first robotic radical cystectomy, a surgical procedure to treat invasive cancer of the bladder. Dr. Rajesh Laungani, Director of Robotic Urology at Saint Joseph’s, performed the minimally-invasive surgery. "This is an uncommon procedure due to its complexity," said Dr. Laungani.
Invasive bladder cancer has a very high mortality rate and generally results in death if not treated. During a radical cystectomy, the entire bladder (and prostate, if the patient is male) is removed. "Performing this robotically allows for a minimally invasive approach," says Laungani. "The advantages include less blood loss, less pain, and quicker recovery. Just as importantly, it provides comparable rates of cancer cure as compared to more traditional surgery."....Read about Dr. Laungani
CANADA VENTURE: Building A Better Medical Robot January 6, 2010 By Monica Gutschi
Of DOW JONES NEWSWIRES
Amadeus is set to challenge da Vinci - at least in the sterile world of microsurgery.
Amadeus is a robotic surgery platform being developed by Toronto-based Titan Medical Inc. (TMD.V). Its aim is to improve upon the da Vinci robotic device developed by Intuitive Surgical Inc. (ISRG) about 12 years ago.
"Titan's interest is to come up with the next-generation platform that has a couple of key technological innovations," says Reiza Rayman, the company's president, co-founder and a medical doctor who holds a graduate degree in robotic telesurgery.
Dr. Wayne Poll founded Minimally Invasive Devices to launch FloShield
Keeping It Clean With Minimally Invasive Products Tuesday, January 05, 2010
Q & A: Wayne Poll, MD, CEO of Minimally Invasive Devices, Inc. How a surgeon founded his own company to launch FloShield, a device that keeps the laparoscope lens clean, addressing a long-felt frustration in the OR and becoming Surgical Products' first ESP Award winner.
Wayne Poll, MD, is a minimally invasive surgeon and the Director of Medical Innovation for OhioHealth in Columbus, OH. He is also the creator of FloShield, a device that helps to keep the laparoscope lens clean and fog-free during surgery. Additionally, he can now add winner of the first annual Excellence In Surgical Products Award to his credentials. To develop FloShield, Dr. Poll founded Minimally Invasive Devices, Inc., and launched the product in August 2009.
After seeing early market adoption of the device, Dr. Poll is leaving his practice in December to run the company as a full-time CEO. Surgical Products talks with Dr. Poll to discuss the winning ESP Award product, what it offers to laparoscopic surgeons, and the story behind how a surgeon with an idea started his own successful company. To read interview Click here
is the first medical device ever designed to prevent fog and aerosolized debris from attaching to the end of the laparoscope.
Available in two versions, FloShield™ and FloShield™PLUS, the system is designed to eliminate or greatly reduce the need to remove the laparoscope for cleaning during surgery.
FloShield™ produces a continuous “air-curtain” over the end of the scope that can eliminate fog and deflect smoke and debris, such as that from various energy sources. FloShield™PLUS integrates a user activated saline flush that can wash debris from the front of the lens without scope removal.
For more information on this product go to FloShield
The Year in Robotics
December 29, 2009
During the past 12 months, robots got better at grasping, smiling, and avoiding angry humans.
While commercial medical robots such as the da Vinci Surgical System continued to appear in hospitals throughout the country, other researchers focused on how to improve rehabilitation devices designed to monitor and correct a patient's movement. Knee, pelvic, and hand rehabilitation devices created at Northeastern University use electro-rheological fluid in their motors. This fluid creates resistance when a current is applied, eliminating the need for more hefty or expensive motors ("Robo-Rehab at Home"). The new motors mean that the smart rehabilitation devices are relatively portable and lightweight, so that poststroke patients can continue physical therapy at smaller medical centers or at home.
Another interesting rehabilitation device that debuted this year is based on a modified game controller. The brainchild of researchers at George Mason University, the system is designed to assist with repetitive handwriting exercises. The device, which is relatively cheap and designed to be used at home, may help improve fine motor control in the hands of children with ADHD or mild cognitive impairments ("Cheaper Robot Rehabilitation").
And for soldiers in the field, researchers created a robotic snake to check for signs of breathing and to deliver oxygen, if needed ("A Robomedic for the Battlefield"). The robot, based on a system originally developed for heart surgery, attaches to a stretcher so the patient can be monitored during transport.
Surgical robots await medical, investment acceptance December 16, 2009. By Marc Songini, Special to Mass High Tech
The remotely controlled, robot-assisted surgery technology pie is a promising one. Yet, for Massachusetts investors, scientists and doctors, a number of obstacles are blocking them from a hefty slice.
Despite their newness, cost, big size and special training requirements, these systems are helping physicians, observed Hiep Nguyen, a urologist at Children’s Hospital. Since 2001, specially trained surgeons at Children’s have been deploying robots in complicated procedures. With robotic procedures, surgeons are more effective and patients recover faster and endure less pain, among other benefits, he said.
As an example, it would normally take a proficient surgeon about two to three minutes to tie a knot with conventional laparoscopy. However, with the robot, it can take just 10 to 30 seconds. A standard laparoscopic pyeloplasty — kidney operation — can take four to five hours, but with the robot it may take only one to two hours. His research has also indicated that the quality of the surgery performed by the robot is superior to that of manual laparoscopy.
Those benefits have resulted at a growth rate of 50 percent annually since 2004 for the leading surgical robotic system, according to Mark Manasas, manager of the surgical and interventional products group at Boston-based Cambridge Consultants Inc. The firm offers consulting services for engineering and technology development, including the field of robotic surgery.
“It’s part of a big tide,” said Kathleen Hagan, president of Watertown-based management consultancy Hagan & Co., who oversaw a study of the Massachusetts robotics industry last year. “The fact that it’s gotten so big so fast tells you the market is here.”.....for complete story Clik here
Dr. David Samadi, MD
Dr. David Samadi, MD Demonstrates a Robotic Surgery on Fox News' Ask Dr. Manny Show December 15, 2009
Dr. David B. Samadi, a world renowned robotic surgery expert and Chief of Robotics and Minimally Invasive Surgery at The Mount Sinai Medical Center in New York City, appeared on the Ask Dr. Manny show to demonstrate the effectiveness of robotic prostatectomy with the use of the da Vinci robot. In his show segment, "Amazing Surgeries," Dr. Alvarez, also the managing editor of health news at Foxnews.com, touted Dr. Samadi as "the king of robotic surgery." "R2D2 meets modern medicine," said Dr. Manny Alvarez when he gave viewers of his November 16th show a true "inside" look at robotic surgery with Samadi at the controls.
Core News Facts:
•Dr. Samadi began working with robots in 2001
•He performs multiple prostate cancer surgeries in one day with his highly skilled surgical team at Mount Sinai
•He has performed over 2,100 successful robotic prostatectomies in his practice
•Dr. Samadi views robotics as an exciting "new era of surgery"
•He believes that 90 percent of treatment outcomes depend on the experience of the surgeon
•Samadi is a multi-disciplined surgeon who is also trained in laparoscopic and open prostate surgery
•In the surgery, the abdomen is distended to give the surgeon more space to work with
•The robotic arms are attached to laparoscopic trocars, which are then inserted into the patient's abdomen
•The surgeon at a nearby console communicates with the robotic arms controlling the instruments inside the patient
•The surgeon's movement is translated to the robotic arms, which filter out any manual tremors in the instruments.
•Robotic prostatectomy is an accurate and bloodless removal of the prostate gland and surrounding lymph nodes, if needed
•Surgeries typically take about 90 minutes and the patient's time in recovery is usually about two hours
•Patients are usually discharged the same day and can resume normal activities within 10 days
•Blood loss is only about 50cc, compared to blood loss with open surgery, which is about 500-1000 cc
•Ideal candidates for robotic surgery are those with early stage, organ-confined cancer. The primary goal is cancer cure in addition to preserving urinary control and sexual function
•Dr. Samadi encourages patients to research surgeons and the volume of cases they have performed and get second opinions. See video below Story by Marketwire
Any medical information published on this website is intended purely as a informational tool only and is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional.
The Copyright of all images and documents is by the According Developing Group, Institute, Editor or Company. We only included data and images freely accessible. We have linked each image and/or story back to it's original source. If you want your system or certain information on it removed from our website, please contact us at firstname.lastname@example.org